Methods and products which utilize Nacyl-L-aspartic acid

Details for Australian Patent Application No. 2004275821 (hide)

Owner DMI Biosciences Inc.

Inventors Bar-Or, David; Rael, Leonard T.

Agent Pizzeys

Pub. Number AU-A-2004275821

PCT Pub. Number WO2005/030083

Priority 60/506,323 25.09.03 US

Filing date 24 September 2004

Wipo publication date 7 April 2005

International Classifications

A61K 31/195 (2006.01)

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/030083 Priority application(s): WO2005/030083

22 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275823-4- (1H-indol-3-yl-methylideneaminoxy-pro poxy) -benzioc acid derivatives and related compounds as PAI-1 inhibitors for the treatment of impairment of the fibrinolytic system and of thrombisis

2004275818-Polyaxial bone screw with torqueless fastening